Skip to main content
Clinical Trials/DRKS00011067
DRKS00011067
Completed
Phase 4

Determination of the Antibacterial Effect of Biodentine in vivo - Identification of Polybacterial 16S rRNA Genes in Caries Samples by T-RFLP and Direct Sequencing

Septodont0 sites10 target enrollmentSeptember 15, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
K02
Sponsor
Septodont
Enrollment
10
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 15, 2016
End Date
May 11, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Septodont

Eligibility Criteria

Inclusion Criteria

  • Primary carious dentine lesions at 2 (or more) molars or premolars which are not in contact (e.g. in different sextants), indication to perform a stepwise caries therapy irrespective of the study
  • \-clinical Picture: according to the International Caries Detection and Assessment System (ICDAS) 4, 5 or 6
  • \-complete isolation by rubberdam is possible
  • \-radiographic extension up to the inner half of the dentine (R4\-lesions)
  • \-no clinical symptoms of the study teeth
  • \-positive sensitivity of the study teeth
  • in cases of carious lesion(s) or insufficient restoration margins in proximity of one of the study cavities: clinically acceptable restoration before trial conduction starts
  • signed informed consent

Exclusion Criteria

  • cases of known intolerance of dental materials (or one of their ingrediences) applied in the study course
  • reasons which make it unlikely to be able to determine the outcome or probable consequences of the study (e.g. alcoholism, mental disability)
  • pregnancy, breastfeeding
  • evidence that keeping treatment appointments will not be able

Outcomes

Primary Outcomes

Not specified

Similar Trials